Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.25 USD | +0.23% | -1.95% | -8.82% |
13/05 | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
10/05 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.82% | 1.79TCr | |
-5.43% | 18TCr | |
+4.30% | 11TCr | |
-3.09% | 6.84TCr | |
+5.86% | 5.25TCr | |
+8.15% | 4.42TCr | |
+7.52% | 4.35TCr | |
+25.54% | 3.27TCr | |
+17.85% | 2.67TCr | |
+1.00% | 2.58TCr |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Stifel Adjusts Baxter International's Price Target to $44 From $50